Breztri Aerosphere 120 Inhalations is used for the maintenance treatment of Chronic Obstructive Pulmonary Disease (COPD) to reduce exacerbations and relieve associated symptoms, such as chronic bronchitis.
Breztri Inhaler Ingredients
It contains a triple-therapy combination of a corticosteroid (Budesonide), a long-acting muscarinic antagonist or LAMA (Glycopyrronium), and a long-acting beta2-adrenergic agonist or LABA (Formoterol). These components work together to dilate the bronchial tubes and open the airways.
What is the Breztri Inhaler used for?
The Breztri inhaler is indicated for:
-
Reducing exacerbations of Chronic Obstructive Pulmonary Disease (COPD), including chronic bronchitis and/or emphysema.
How to use the Breztri Inhaler?
-
The standard dosage is 2 puffs in the morning and 2 puffs in the evening.
-
For oral inhalation only.
Side Effects
Breztri may cause some side effects, including:
-
Nausea.
-
Chest pain.
-
Hyperglycemia (increased blood sugar levels).
-
Headache.
-
Anxiety and insomnia.
Contraindications
The Breztri inhaler should not be used for:
-
Children.
-
Treatment of acute bronchospasm episodes (rescue therapy) or asthma in general.
Warnings and Precautions
Caution should be exercised before using the Breztri inhaler, especially in cases of:
-
Arrhythmia (irregular heartbeat).
-
Adrenal gland disorders.
-
Thyroid disorders.
-
High blood sugar (Diabetes).
-
Hypokalemia (low potassium levels in the blood).
Storage and Handling
-
Keep out of reach of children.
-
Store at a temperature between 15°C and 30°C.
-
Store in a cool, dry place.
